Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cellceutix Corp (OTCQB:CTIX)

1.35
Delayed Data
As of 3:59pm ET
 -0.021 / -1.53%
Today’s Change
0.94
Today|||52-Week Range
2.05
+1.43%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$167.9M

Company Description

Cellceutix Corp. is a clinical stage biotechnology company, which focuses on discovering small molecule drugs for hard to treat diseases, including drug-resistant cancers, psoriasis, autism and inflammatory disease. Its lead cancer compound, Kevetrin, is an anti-cancer drug which has demonstrated the ability in pre-clinical studies to regulate the p53 pathway and attack cancers. The company was founded by Krishna Kumar Menon and Leo Ehrlich in June 20, 2007 and is headquartered in Beverly, MA.

Contact Information

Cellceutix Corp.
100 Cummings Center
Beverly Massachusetts 01915
P:(978) 236-8717
Investor Relations:

Employees

Shareholders

Individual stakeholders21.53%
Other institutional0.00%
Mutual fund holders0.00%

Top Executives

Leo EhrlichChairman, CEO, CFO, Secretary & CAO
Arthur Peter BertolinoPresident & Chief Medical Officer
Krishna Kumar MenonDirector & Chief Science Officer
Daniel JorgensenChief Medical Officer